دورية أكاديمية
Effectiveness of fractional erbium-YAG laser, microneedling, platelet-rich plasma in localized stable vitiligo patients: randomized clinical trial.
العنوان: | Effectiveness of fractional erbium-YAG laser, microneedling, platelet-rich plasma in localized stable vitiligo patients: randomized clinical trial. |
---|---|
المؤلفون: | Abdel-Hamid S; Department of Dermatology, Venereology, and Andrology, Faculty of Medicine, South Valley University, Qena, Egypt. soher.abdel-hamid@med.svu.edu.eg., Ibrahim HM; Department of Dermatology, Venereology, and Andrology, Faculty of Medicine, South Valley University, Qena, Egypt., Hameed AM; Dermatology, Venereology, and Leprosy Hospital, Qena, Egypt., Hegazy EM; Department of Dermatology, Venereology, and Andrology, Faculty of Medicine, South Valley University, Qena, Egypt. |
المصدر: | Archives of dermatological research [Arch Dermatol Res] 2024 Jun 15; Vol. 316 (7), pp. 399. Date of Electronic Publication: 2024 Jun 15. |
نوع المنشور: | Journal Article; Randomized Controlled Trial |
اللغة: | English |
بيانات الدورية: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8000462 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-069X (Electronic) Linking ISSN: 03403696 NLM ISO Abbreviation: Arch Dermatol Res Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: Berlin : Springer Verlag |
مواضيع طبية MeSH: | Vitiligo*/therapy , Vitiligo*/radiotherapy , Vitiligo*/diagnosis , Platelet-Rich Plasma* , Lasers, Solid-State*/therapeutic use , Skin Pigmentation*/radiation effects , Needles*, Humans ; Female ; Male ; Adult ; Treatment Outcome ; Young Adult ; Middle Aged ; Adolescent ; Dry Needling/methods ; Dry Needling/instrumentation ; Combined Modality Therapy/methods ; Percutaneous Collagen Induction |
مستخلص: | Vitiligo is considered an autoimmune disease, and its treatment is challenging. We assessed and compared the effect of fractional erbium:yttrium-aluminum-garnet (Er:YAG) laser-assisted delivery of platelet-rich plasma versus microneedling (Mn) with platelet-rich plasma (PRP) in enhancing skin repigmentation in localized stable vitiligo patients. In total, 40 patients with localized stable vitiligo were selected in a random manner into two similar groups (20 each). Group (A) was subjected to fractional Er:YAG laser combined with platelet-rich plasma and Group (B) was subjected to microneedling combined with platelet-rich plasma. The procedure was repeated every 2 weeks for up to 6 months. Each individual was assessed clinically utilizing Vitiligo Area Scoring Index (VASI). Fractional Er:YAG + PRP group achieved better pigmentation100% (excellent 30%, very good 15%, good 30% and satisfactory 25%) which is comparable to Mn + PRP where 80% of cases demonstrate repigmentation (20% very good, 10% good and 50% mild). When comparing the VASI scores for both groups after therapy to the baseline VASI, there was a statistically significant decrease [p = 0.001 for group(A) and 0.003 for group(B)]. Regarding the treatment side effects, there was significantly (p = 0.048) side effects among cases treated with microneedling group(B) (25%) than those fractional Er:Yag laser therapy group(A) (5%). Both forms of therapy demonstrated induction of repigmentation of vitiligo, but fractional Er:YAG laser efficacy is greater when combined with platelet-rich plasma.Clinical trials.gov identifier: NCT05511493. (© 2024. The Author(s).) |
References: | Clin Cosmet Investig Dermatol. 2018 Nov 08;11:551-559. (PMID: 30510437) J Clin Aesthet Dermatol. 2020 Aug;13(8):28-35. (PMID: 33178379) Genetics. 2006 Nov;174(3):1695-7. (PMID: 16702429) J Cosmet Dermatol. 2020 Jun;19(6):1473-1478. (PMID: 31524967) J Cosmet Dermatol. 2020 Apr;19(4):855-862. (PMID: 32030880) J Cutan Aesthet Surg. 2023 Jul-Sep;16(3):186-191. (PMID: 38189059) Dermatol Ther. 2021 Nov;34(6):e15159. (PMID: 34657363) Behav Res Methods. 2007 May;39(2):175-91. (PMID: 17695343) J Cosmet Dermatol. 2018 Oct;17(5):744-751. (PMID: 29532621) J Cosmet Dermatol. 2024 Jun;23(6):2220-2230. (PMID: 38470079) Photobiomodul Photomed Laser Surg. 2021 Sep;39(9):600-606. (PMID: 34546107) Science. 1908 Jul 10;28(706):49-50. (PMID: 17779291) Skin Health Dis. 2023 Dec 18;4(1):e317. (PMID: 38312261) Annu Int Conf IEEE Eng Med Biol Soc. 2007;2007:3442-5. (PMID: 18002737) Br J Dermatol. 2016 May;174(5):962-9. (PMID: 26686510) Lasers Surg Med. 2014 Aug;46(6):443-8. (PMID: 24889492) J Cosmet Dermatol. 2018 Jun;17(3):365-372. (PMID: 28834191) Lasers Surg Med. 2020 Jan;52(1):61-69. (PMID: 31254291) Ann Dermatol. 2011 Nov;23(4):424-31. (PMID: 22148008) An Bras Dermatol. 2022 Jul-Aug;97(4):478-490. (PMID: 35643735) J Cosmet Dermatol. 2019 Apr;18(2):581-588. (PMID: 30009490) J Cosmet Dermatol. 2018 Apr;17(2):165-170. (PMID: 28722334) Arch Dermatol. 2004 Jun;140(6):677-83. (PMID: 15210457) |
فهرسة مساهمة: | Keywords: Er–YAG laser; Microneedling; Platelet-rich plasma; VASI score; Vitiligo |
سلسلة جزيئية: | ClinicalTrials.gov NCT05511493 |
تواريخ الأحداث: | Date Created: 20240615 Date Completed: 20240615 Latest Revision: 20240618 |
رمز التحديث: | 20240618 |
مُعرف محوري في PubMed: | PMC11180153 |
DOI: | 10.1007/s00403-024-03035-8 |
PMID: | 38878236 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1432-069X |
---|---|
DOI: | 10.1007/s00403-024-03035-8 |